Community intervention to reduce violence and promote resilience
Community Resiliency Collective Efficacy Intervention (CRCEI) for Prevention of Community Violence - A Cluster Randomized Controlled Trial
This study is testing a community program designed to reduce violence and build resilience among people in diverse neighborhoods in Pittsburgh by encouraging discussions and teamwork.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 4600 (estimated) |
| Ages | 13 Years and up |
| Sex | All |
| Sponsor | University of Pittsburgh Academic / other |
| Locations | 1 site (Pittsburgh, Pennsylvania) |
| Trial ID | NCT05768217 on ClinicalTrials.gov |
What this trial studies
This study evaluates the effectiveness of a community-centered intervention aimed at reducing community violence through a cluster-randomized controlled trial. The Community Resiliency Collective Efficacy Intervention (CRCEI) engages community members in discussions about neighborhood transformation, equity, and leadership to foster resilience and thriving among youth and adults. By utilizing a participatory approach and the Community Thriving Matrix tool, the study aims to enhance collective efficacy within neighborhoods. Control neighborhoods will receive health education sessions for comparison. The study focuses on diverse neighborhoods in the Pittsburgh region.
Who should consider this trial
Good fit: Ideal candidates include youth aged 13 years and older and adults 18 years and older residing in selected neighborhoods.
Not a fit: Individuals younger than 13 years old or those living outside the participating neighborhoods may not benefit from this study.
Why it matters
Potential benefit: If successful, this intervention could significantly reduce community violence and enhance the resilience of individuals and neighborhoods.
How similar studies have performed: Other studies have shown success with community-centered interventions aimed at reducing violence, indicating potential for this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * youth age 13 years old and up (all genders) * adults 18 years and older (all genders) * reside in neighborhoods selected to participate in the study Exclusion Criteria: * individuals younger than 13 years old * individuals residing outside of participating neighborhoods
Where this trial is running
Pittsburgh, Pennsylvania
- University of Pittsburgh — Pittsburgh, Pennsylvania, United States (Recruiting)
Study contacts
- Principal investigator: Elizabeth Miller, MD, PhD — University of Pittsburgh
- Study coordinator: Christi Gomez
- Email: clg166@pitt.edu
- Phone: (412) 969-3084
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.